Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults
Open accessAbstract
Importance: Mounting evidence suggests that sex differences exist in the pathologic trajectory of Alzheimer disease. Previous literature shows elevated levels of cerebrospinal fluid tau in women compared with men as a function of apolipoprotein E (APOE) ε4 status and β-amyloid (Aβ). What remains unclear is the association of sex with regional tau deposition in clinically normal individuals. Objective: To examine sex differences in the cross-sectional association between Aβ and regional tau deposition as measured with positron emission tomography (PET). Design, Setting and Participants: This is a study of 2 cross-sectional, convenience-sampled cohorts of clinically normal individuals who received tau and Aβ PET scans. Data were collected between January 2016 and February 2018 from 193 clinically normal individuals from the Harvard Aging Brain Study (age range, 55-92 years; 118 women [61%]) who underwent carbon 11-labeled Pittsburgh Compound B and flortaucipir F18 PET and 103 clinically normal individuals from the Alzheimer's Disease Neuroimaging Initiative (age range, 63-94 years; 55 women [51%]) who underwent florbetapir and flortaucipir F 18 PET. Main Outcomes and Measures: A main association of sex with regional tau in the entorhinal cortices, inferior temporal lobe, and a meta-region of interest, which was a composite of regions in the temporal lobe. Associations between sex and global Aβ as well as sex and APOE ε4 on these regions after controlling for age were also examined. Results: The mean (SD) age of all individuals was 74.2 (7.6) years (81 APOE ε4 carriers [31%]; 89 individuals [30%] with high Aβ). There was no clear association of sex with regional tau that was replicated across studies. However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = -0.11 [0.05]; 95% CI, -0.21 to -0.02; P = .02), which was associated with individuals with higher Aβ burden. A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = -0.15 [0.09]; 95% CI, -0.32 to 0.01; P = .07). Conclusions and Relevance: Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory. These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.
AI snapshot
Written from the paper’s full text.
TL;DR
In two clinically normal older-adult cohorts, women showed higher entorhinal cortical tau than men, particularly among individuals with higher global amyloid burden, although sex differences were not consistently replicated across all regional tau measures. The findings suggest early tau deposition may be elevated in women on the Alzheimer disease trajectory.
Key findings
- There was no clear association of sex with regional tau that replicated across studies, but clinically normal women exhibited higher entorhinal cortical tau than men in both cohorts (meta-analytic estimate: β [male] = −0.11 [0.05]; 95% CI, −0.21 to −0.02; P = .02).
- The sex difference in entorhinal tau was associated with higher Aβ burden: meta-analytic sex × Aβ interaction β (male, Aβ+) = −0.19 (0.06); 95% CI, −0.32 to −0.07; P = .002.
- A sex × APOE ε4 interaction was not significantly associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = −0.15 [0.09]; 95% CI, −0.32 to 0.01; P = .07).
- In ADNI only, a sex × APOE ε4 interaction was found for the tau meta-ROI (β = −0.30; 95% CI, −0.58 to −0.02; P = .04), with a stronger APOE ε4–tau association among women than men.
Methods
- Cross-sectional study of two convenience-sampled clinically normal cohorts: 193 individuals from the Harvard Aging Brain Study (HABS; age range, 55–92 years; 118 women [61%]) and 103 from the Alzheimer’s Disease Neuroimaging Initiative (ADNI; age range, 63–94 years; 55 women [51%]).
- Participants received tau PET with [18F]flortaucipir and Aβ PET ([11C]PiB in HABS; [18F]florbetapir in ADNI); tau regions included entorhinal cortex, inferior temporal cortex, a temporal meta-ROI, and extratemporal precuneus and superior parietal regions.
- Hierarchical linear regressions examined sex, Aβ, and APOE ε4 associations with regional tau after adjusting for age and scan interval, followed by fixed-effect meta-analysis of standardized coefficients across cohorts.
Limitations
- The paper states that both cohorts are convenience samples with recruitment and sampling biases that may limit generalizability; it also notes possible sex-specific partial volume effects, though no association of gray matter volume with the findings was found.
- The paper states that exploratory analyses of sex × entorhinal tau on cognitive decline were null and should be interpreted cautiously because of limited power and follow-up; it also notes unresolved survival bias and limited power to examine APOE and 3-way interactions.
- Evident from the text: the cross-sectional design cannot establish temporal or causal ordering, and APOE genotype data were missing for some participants (n = 34 in HABS; n = 7 in ADNI).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
24 of 27 cited sources checked · 16 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Sex differences in Aβ burden alone have not been reported in older adults.
“Sex differences in Aβ burden alone have not been reported in older adults,11–13”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [11] Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer’s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75 (4): 563– 573. doi: 10.1002/ana.24135 24623176 PMC4117990 source
The Discussion reports similar beta-amyloid levels in men and women with MCI and a pronounced APOE4 effect on beta-amyloid in healthy older adults of both sexes. However, the Results (CSF Biomarkers; page not provided) report a nominal sex-by-APOE4 interaction for CSF Aβ in healthy controls that did not survive correction for multiple tests. These findings support the absence of a robust difference in this study, but not the broader assertion that sex differences in Aβ burden have never been reported in older adults. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [12] Mielke MM, Wiste HJ, Weigand SD, Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 2012; 79(15): 1570– 1577.doi: 10.1212/WNL.0b013e31826e2696 22972644 PMC3475629 source
- cites [13] Morris JC, Roe CM, Xiong C, APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann Neurol. 2010; 67(1): 122– 131. doi: 10.1002/ana.21843 20186853 PMC2830375 source
- Premisecitation
Sex differences may be more likely to appear downstream after the onset of Aβ accumulation.
“supporting the notion that sex differences may be more likely to appear downstream after the onset of Aβ accumulation.5,10”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [5] Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer’s disease. Horm Behav. 2013; 63 (2): 301– 307. doi: 10.1016/j.yhbeh.2012.04.006 22554955 PMC3413783 source
The ‘Females, menopause, and risk of AD’ section reports sex differences in Aβ accumulation, neuropathology, and behavioral performance in transgenic mice. It does not establish that sex differences are more likely to emerge only downstream of the onset of Aβ accumulation; it reports differences in Aβ accumulation itself. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [10] Hohman TJ, Dumitrescu L, Barnes LL,; Alzheimer’s Disease Genetics Consortium and the Alzheimer’s Disease Neuroimaging Initiative. Sex-specific association of Apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018; 75(8): 989– 998. doi: 10.1001/jamaneurol.2018.0821 29801024 PMC6142927 source
- Premisecitation
Mounting evidence suggests that women are at heightened risk for exhibiting Alzheimer disease pathophysiology.
“although mounting evidence suggests that women are at heightened risk for exhibiting AD pathophysiology.5–8”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [5] Vest RS, Pike CJ. Gender, sex steroid hormones, and Alzheimer’s disease. Horm Behav. 2013; 63 (2): 301– 307. doi: 10.1016/j.yhbeh.2012.04.006 22554955 PMC3413783 source
- cites [6] Mosconi L, Berti V, Quinn C, Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. Neurology. 2017; 89(13): 1382– 1390. 28855400 PMC5652968 source
- cites [7] Laws KR, Irvine K, Gale TM. Sex differences in Alzheimer’s disease. CurrOpin Psychiatry. 2018; 31 (2): 133– 139. doi: 10.1097/YC0.0000000000000401 29324460 source
- cites [8] Fisher DW, Bennett DA, Dong H. Sexual dimorphism in predisposition to Alzheimer’s disease. Neurobiol Aging. 2018; 70: 308– 324. doi: 10.1016/j.neurobiolaging.2018.04.004 29754747 PMC6368179 source
- Premisecitation
In clinically normal older adults and individuals with mild cognitive impairment, higher cerebrospinal fluid tau levels have been observed in female APOE ε4 carriers compared with male carriers.
“In clinically normal older adults9,10 and individuals with mild cognitive impairment,11 higher cerebrospinal fluid (CSF) tau levels have been observed in female apolipoprotein E (APOE) ε4 carriers compared with male carriers.”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [9] Damoiseaux JS, Seeley WW, Zhou J,; Alzheimer’s Disease Neuroimaging Initiative. Gender modulates the APOE ε4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J Neurosci. 2012; 32(24): 8254– 8262. doi: 10.1523/JNEUROSCI.0305-12.2012 22699906 PMC3394933 source
- cites [10] Hohman TJ, Dumitrescu L, Barnes LL,; Alzheimer’s Disease Genetics Consortium and the Alzheimer’s Disease Neuroimaging Initiative. Sex-specific association of Apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018; 75(8): 989– 998. doi: 10.1001/jamaneurol.2018.0821 29801024 PMC6142927 source
The Results (Sex × APOE Interactions) report a stronger association between APOE ε4 and CSF tau in females than in males. The Materials and Methods say an included cohort contained people with mild cognitive impairment, but the reported result is pooled rather than specific to that group. Post hoc Results also indicate that the sex difference was observed in amyloid-positive, not amyloid-negative, individuals. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [11] Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer’s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75 (4): 563– 573. doi: 10.1002/ana.24135 24623176 PMC4117990 source
- Premisecitation
The cross-sectional association between regional tau PET and global Aβ PET is well-characterized.
“we examined the influence of sex to modify the well-characterized cross-sectional association between regional tau PET and global Aβ PET.14–16”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [14] Johnson KA, Schultz A, Betensky RA, Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol. 2016; 79 (1): 110– 119. doi: 10.1002/ana.24546 26505746 PMC4738026 source
- cites [15] Brier MR, Gordon B, Friedrichsen K, Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease. Sci Transl Med. 2016; 8(338): 338ra66. doi: 10.1126/scitranslmed.aaf2362 PMC5267531 27169802 source
The Results section ('PET tau and Aβ, in distinct topographies, are strongly correlated'; page unavailable) reports a strong cross-sectional association between regional tau PET and Aβ PET topographies. It does not establish the specifically claimed association with a global Aβ PET measure; its Aβ measure in that analysis is a weighted regional topography. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [16] Maass A, Landau S, Baker SL,; Alzheimer’s Disease Neuroimaging Initiative. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer’s disease. Neuroimage. 2017; 157: 448– 463. doi: 10.1016/j.neuroimage.2017.05.058 28587897 PMC5814575 source
- Premisecitation
Female APOE ε4 carriers with abnormal levels of CSF Aβ also exhibit higher CSF tau than male carriers.
“Female APOE ε4 carriers with abnormal levels of CSF Aβ also exhibit higher CSF tau than male carriers.10”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [10] Hohman TJ, Dumitrescu L, Barnes LL,; Alzheimer’s Disease Genetics Consortium and the Alzheimer’s Disease Neuroimaging Initiative. Sex-specific association of Apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018; 75(8): 989– 998. doi: 10.1001/jamaneurol.2018.0821 29801024 PMC6142927 source
- Premisecitation
Epidemiologic studies show sex differences in clinical risk are largely discernable within the context of APOE ε4, particularly between the ages of 65 to 75 years compared with APOE ε4 clinically normal male carriers.
“Epidemiologic studies show sex differences in clinical risk are largely discernable within the context of APOE ε4,11,42,43 particularly between the ages of 65 to 75 years compared with APOE ε4 clinically normal male carriers.44”
Quote in the paperNot a substantial claim3 of 4 sources checked- cites [11] Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer’s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75 (4): 563– 573. doi: 10.1002/ana.24135 24623176 PMC4117990 source
The Results (Clinical Conversion Risks; page unavailable) report a stronger APOE ε4–associated risk of conversion in clinically normal older women than in men, supporting the sex-difference point. They do not identify ages 65–75 as a particularly pronounced interval, and their reported risk estimates compare carriers with non-carriers within each sex rather than directly comparing female carriers with male carriers. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [42] Beydoun MA, Boueiz A, Abougergi MS, Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiol Aging. 2012; 33 (4): 720– 731. doi: 10.1016/j.neurobiolaging.2010.05.017 20619505 PMC2974952 source
The Results and Discussion (pages unavailable) report stronger APOE ε4 associations with some cognitive outcomes in women than men, although the sex difference in dementia risk was not statistically significant. The Results also note higher dementia incidence among carriers by age 75, but do not establish a sex difference specifically at ages 65–75 or a comparison with clinically normal male carriers. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [43] Farrer LA, Cupples LA, Haines JL,; APOE and Alzheimer Disease Meta Analysis Consortium. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997; 278(16): 1349– 1356. doi: 10.1001/jama.1997.03550160069041 9343467 source
- cites [44] Neu SC, Pa J, Kukull W, Apolipoprotein E genotype and sex risk factors for Alzheimer disease: a meta-analysis. JAMA Neurol. 2017; 74(10): 1178– 1189. doi: 10.1001/jamaneurol.2017.2188 28846757 PMC5759346 source
- Premisecitation
Minimal, if any, sex differences have been found cross-sectionally in levels of global Aβ burden in clinically normal older adults.
“Minimal,6 if any,11,12,36 sex differences have been found cross sectionally in levels of global Aβ burden in clinically normal older adults”
Quote in the paperNot a substantial claim4 of 4 sources checked- cites [6] Mosconi L, Berti V, Quinn C, Sex differences in Alzheimer risk: brain imaging of endocrine vs chronologic aging. Neurology. 2017; 89(13): 1382– 1390. 28855400 PMC5652968 source
The Results (Participants section; page unavailable) report significant sex differences in PiB uptake in specific brain regions, not global Aβ burden. The study examined cognitively normal adults aged 40–60, so its cross-sectional findings do not establish whether global Aβ burden differs minimally, if at all, between sexes in clinically normal older adults. I searched the indexed copy for global amyloid burden and sex differences. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [11] Altmann A, Tian L, Henderson VW, Greicius MD; Alzheimer’s Disease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014; 75 (4): 563– 573. doi: 10.1002/ana.24135 24623176 PMC4117990 source
The Results (CSF Biomarkers; page unavailable) found no statistically significant APOE4-by-sex interaction in CSF Aβ levels among healthy controls after correction for multiple testing, which supports the cited word “minimal.” The paper measured CSF Aβ and tested an APOE4-by-sex interaction; it did not establish minimal sex differences in global Aβ burden. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [12] Mielke MM, Wiste HJ, Weigand SD, Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology. 2012; 79(15): 1570– 1577.doi: 10.1212/WNL.0b013e31826e2696 22972644 PMC3475629 source
- cites [36] Buckley RF, Mormino EC, Amariglio RE,; Alzheimer’s Disease Neuroimaging Initiative; Australian Imaging, Biomarker and Lifestyle study of ageing; Harvard Aging Brain Study. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer’s disease: Findings from three well-characterized cohorts. Alzheimers Dement. 2018; 14(9): 1193– 1203.doi: 10.1016/j.jalz.2018.04.010 29803541 PMC6131023 source
- Findingown data
The HABS sex × Aβ model was significantly better-fitting than the main effects-only model (log likelihood ratio: 4.42, P = .04).
“This was a significantly better-fitting model than the main effects-only model (model 1 vs model 3 log likelihood ratio: 4.42, P = .04).”
Quote in the paperSubstantial claim - Findingown data
The ADNI sex × Aβ effect remained significant with robust linear regression (robust F = 5.55, P = .02).
“and remained significant with robust linear regression (robust F = 5.55, P = .02).”
Quote in the paperSubstantial claim - Findingown data
In HABS, unadjusted analyses showed no sex differences in any temporal tau regions or in global Aβ distribution volume ratio.
“In the HABS clinically normal group, using a simple group comparison without adjusting for age, no sex differences existed in any temporal tau regions or in global Aβ distribution volume ratio (eFigure in the Supplement).”
Quote in the paperNot a substantial claim - Findingown data
When removing the outlying women with higher levels of amyloid than men (n = 7), the sex differences remained (β = −0.29; 95% CI, −0.55 to −0.02; P = .04).
“When removing the outlying women with higher levels of amyloid than men (n = 7), the sex differences remained (β = −0.29; 95% CI, −0.55 to −0.02; P = .04).”
Quote in the paperNot a substantial claim - Findingown data
The sex difference in entorhinal cortical tau was associated with individuals with higher Aβ burden (meta-analytic sex × Aβ interaction: β [male, Aβ+] = −0.19 [0.06]; 95% CI, −0.32 to −0.07; P = .002).
“which was associated with individuals with higher Aβ burden.”
- Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
“the interaction between sex and Aβ on EC tau SUVr was significant: β (male, Aβ+) = −0.19 (0.06) [95% CI, −0.32 to −0.07], P = .002.”
Quote in the paperSubstantial claim - Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
- Findingown data
A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = −0.15 [0.09]; 95% CI, −0.32 to 0.01; P = .07).
“A sex by APOE ε4 interaction was not associated with regional tau (meta-analytic estimate: β [male, APOE ε4+] = −0.15 [0.09]; 95% CI, −0.32 to 0.01; P = .07).”
- Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
“The interactive effect of sex and APOE on EC tau SUVr was not significant, β (male, ε4+) = −0.15 (0.09); 95% CI, −0.32 to 0.01; P = .07”
Quote in the paperNot a substantial claim - Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
- Findingown data
To observe a sex difference of 10% tau signal in the entorhinal cortex in clinically normal individuals, global Aβ was estimated at approximately 1.40 [11C]PiB distribution volume ratio in HABS and 1.10 florbetapir SUVr in ADNI.
“To observe a sex difference of 10% tau signal in the EC in clinically normal individuals, global Aβ was estimated at approximately 1.40 [11C]PiB distribution volume ratio in HABS (published cutpoint = 1.2 distribution volume ratio34) and 1.10 florbetapir SUVr in ADNI (published cut point = 1.1122; Figure 2 and eTable 5 in the Supplement).”
Quote in the paperNot a substantial claim - Findingown data
An exploratory 3-way interaction between sex, APOE, and Aβ was not significant (β [male, ε4+, Aβ+] = 0.01 [0.09]; 95% CI, −0.16 to 0.18; P = .91).
“An exploratory examination of a 3-way interaction between sex, APOE, and Aβ was not significant: β (male, ε4+, Aβ+) = 0.01 (0.09); 95% CI, −0.16 to 0.18; P = .91.”
Quote in the paperNot a substantial claim - Findingown data
In ADNI, women exhibited higher median entorhinal cortex tau SUVr than men by 5.8% (M-W = 1699, P = .01).
“However, in the ADNI clinically normal group, women exhibited higher median EC tau SUVr than men by 5.8% (M-W = 1699, P = .01).”
Quote in the paperSubstantial claim - Findingown data
HABS clinically normal individuals performed significantly better on logical memory delayed recall than ADNI clinically normal individuals.
“Clinically normal individuals in HABS performed significantly better onlogical memory (delayed recall) than their ADNI counterparts (t = −5.56, P < .001)”
Quote in the paperNot a substantial claim - Findingown data
In HABS, sex and APOE did not interact to influence tau retention.
“For the HABS clinically normal group, sex and APOE did not interact to influence tau retention (model 4; Figure 2).”
Quote in the paperSubstantial claim - Findingown data
After adjusting for age, clinically normal women in ADNI showed slightly elevated inferior temporal tau SUVr compared with men (robust F test = 4.33, P = .04).
“Adjusting for age yielded no changes to the above findings, except that clinically normal women in ADNI now showed slightly elevated IT tau SUVr compared with clinically normal men in ADNI (robust F test = 4.33, P = .04).”
Quote in the paperNot a substantial claim - Findingown data
The HABS sex × Aβ finding became attenuated using robust regression analysis (robust F for sex β Aβ = 4.64, P = .08).
“The finding became attenuated using robust regression analysis (robust F for sex β Aβ = 4.64, P = .08).”
Quote in the paperNot a substantial claim - Findingown data
In both HABS and ADNI, clinically normal women showed higher entorhinal cortex tau retention than clinically normal men with higher Aβ burden.
“In conclusion, clinically normal women from both the HABS and ADNI studies showed higher EC tau retention than in clinically normal men with higher Aβ burden (full models in eTable 3 in the Supplement).”
- Also stated in: § Discussion · plain
“Clinically normal women exhibited higher EC tau than men in individuals with higher Aβ burden across both cohorts.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · plain
- Findingown data
In both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = −0.11 [0.05]; 95% CI, −0.21 to −0.02; P = .02).
“However, in both cohorts, clinically normal women exhibited higher entorhinal cortical tau than men (meta-analytic estimate: β [male] = −0.11 [0.05]; 95% CI, −0.21 to −0.02; P = .02)”
- Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
“we found that the main effect of sex on EC tau SUVr was significant: β (male) = −0.11 (0.05); 95% CI, −0.21 to −0.02; P = .02.”
Quote in the paperSubstantial claim - Also stated in: § Meta-analytic Estimate of Sex Difference on EC Tau · plain
- Findingown data
The ADNI sex × Aβ model fit significantly better than the main effects-only model (F = 5.57, P = .02).
“This model fit significantly better than the main effects-only model (model 1 vs model 3 log likelihood ratio: F = 5.57, P = .02)”
Quote in the paperSubstantial claim - Findingown data
The ADNI sex × APOE model fit significantly better than a main effects-only model (F = 4.37, P = .04).
“This model fit significantly better than a main effects-only model (F = 4.37, P = .04).”
Quote in the paperSubstantial claim - Findingown data
There was no clear association of sex with regional tau that was replicated across studies.
“There was no clear association of sex with regional tau that was replicated across studies.”
Quote in the paperSubstantial claim - Findingown data
In HABS, women exhibited higher entorhinal cortex tau SUVr than men in individuals with higher Aβ burden (β = −0.17; 95% CI, −0.32 to −0.01; P = .04).
“In the HABS clinically normal group, women exhibited higher EC tau SUVr than men in individuals with higher Aβ burden (β = −0.17; 95% CI, −0.32 to −0.01; P = .04; Table 2 and Figure 1).”
Quote in the paperSubstantial claim - Findingown data
Both HABS and ADNI clinically normal women showed elevated signal in the superior parietal ROI compared with men after adjusting for age (HABS: β = −0.29; 95% CI, −0.42 to −0.15; P < .001; ADNI: β = −0.23; 95% CI, −0.40 to −0.06; P = .01).
“However, both clinically normal HABS and ADNI women showed elevated signal in the superior parietal ROI compared with men, after adjusting for age (β = −0.29; 95% CI, −0.42 to −0.15; P < .001 for HABS and β = −0.23; 95% CI, −0.40 to −0.06; P = .01 for ADNI).”
Quote in the paperSubstantial claim - Findingown data
We did not find a significant influence of gray matter volume on our results.
“We did not find a significant influence of gray matter volume on our results.”
Quote in the paperNot a substantial claim - Findingown data
In ADNI, women showed higher entorhinal cortex tau compared with men (β = −0.23; 95% CI, −0.42 to −0.04) in individuals with higher Aβ burden.
“In the ADNI clinically normal group, women also showed higher EC tau compared with men (β = −0.23; 95% CI, −0.42 to −0.04) in individuals with higher Aβ burden (Figure 1).”
Quote in the paperSubstantial claim - Findingown data
No sex differences were evident in the precuneus ROI in either cohort.
“No sex differences were evident in the precuneus ROI in either cohort (eTable 4 in the Supplement).”
Quote in the paperSubstantial claim - Findingown data
We did not find a significant interactive sex × entorhinal cortex tau association with cognitive decline.
“We did not find a significant interactive sex × EC tau association with cognitive decline (eTable 2 in the Supplement).”
Quote in the paperSubstantial claim - Findingown data
In the current study, we found a trend toward slightly higher median Aβ values in women.
“In the current study, we found a trend toward slightly higher median Aβ values in women, similar to a 2018 study.38”
Quote in the paperNot a substantial claim - Findingreasoning
The magnitude of association was notably higher in the ADNI clinically normal group than in the HABS clinically normal group.
“However, the magnitude of association was notably higher in the ADNI clinically normal group”
- Also stated in: § Conclusions · boosted
“These findings were stronger in the ADNI clinically normal cohort in comparison with the HABS clinically normal group”
Quote in the paperNot a substantial claim - Also stated in: § Conclusions · boosted
- Interpretationown data
These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.
“These findings lend support to a growing body of literature that highlights a biological underpinning for sex differences in Alzheimer disease risk.”
- Also stated in: § Conclusions · plain
“with our findings lending support to a growing body of literature that exposes a biological underpinning for sex differences in AD risk.”
Quote in the paperNot a substantial claim - Also stated in: § Conclusions · plain
- Interpretationown data
The association may carry some level of specificity, as other extratemporal regions did not exhibit this interactive Aβ-by-sex effect on tau signal.
“Further, this association may carry some level of specificity, as other extratemporal regions did not exhibit this interactive Aβ-by-sex effect on tau signal.”
Quote in the paperNot a substantial claim - Interpretationown data
Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory.
“Early tau deposition was elevated in women compared with men in individuals on the Alzheimer disease trajectory.”
Quote in the paperSubstantial claim - Study design and conductown data
Analyses excluding participants with a delay of longer than a year between scans showed the same pattern of findings.
“We also ran analyses without these aforementioned individuals, and the pattern of findings remained the same.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Early tau deposition may be accelerated in women compared with men.
“As such, early tau deposition may be accelerated in women compared with men, with our findings lending support to a growing body of literature that exposes a biological underpinning for sex differences in AD risk.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 16
- May combine two claims. 12
Classified as probably not a substantial claim.
PremisecitationSex differences exist in brain morphology.
“As sex differences exist in brain morphology,33”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Ritchie SJ, Cox SR, Shen X, Sex differences in the adult human brain: evidence from 5,216 UK Biobank participants. Cereb Cortex. 2018; 28(8): 2959– 2975. doi: 10.1093/cercor/bhy109 29771288 PMC6041980 source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAPOE ε4 is highly associated with Aβ.
“given that APOE ε4 is highly associated with Aβ,45”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [45] Lim YY, Mormino EC; Alzheimer’s Disease Neuroimaging Initiative. APOE genotype and early β-amyloid accumulation in older adults without dementia. Neurology. 2017; 89(10): 1028– 1034. doi: 10.1212/WNL.0000000000004336 28794245 PMC5589795 source
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataWomen exhibited higher scores on logical memory delayed recall in the HABS clinically normal group.
“Women exhibited higher scores on logical memory delayed recall in the HABS clinically normal group (Table 1)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn ADNI, a sex × APOE ε4 interaction was found with the tau meta-ROI (β = −0.30; 95% CI, −0.58 to −0.02; P = .04), whereby the association between APOE ε4 and tau retention was stronger among women compared with men.
“For the ADNI clinically normal group, a sex × APOE ε4 interaction term was found with the tau meta-ROI (β = −0.30; 95% CI, −0.58 to −0.02; P = .04; model 4), whereby the association between APOE ε4 and tau retention was stronger among women compared with men.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNeither cohort showed significant interactions of sex × Aβ or sex × APOE on either extratemporal ROI.
“Neither cohort showed significant interactions of sex × Aβ or sex × APOE on either extratemporal ROI.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere was no sex-Aβ interaction on either inferior temporal tau or the tau meta-ROI in HABS.
“There was no sex-Aβ interaction on either IT tau or the meta-ROI.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataNo sex differences were found in demographics in the ADNI clinically normal group.
“however, no sex differences were found in demographics in the ADNI clinically normal group.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataHABS and ADNI clinically normal individuals did not differ by age, sex, Aβ+ status, or APOE ε4 status.
“but did not differ by age, sex, Aβ+ status, or APOE ε4 status.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataClinically normal men in the ADNI group showed lower dynamic range for Aβ and lower inferior temporal tau retention compared with women.
“Clinically normal men in the ADNI group, for instance, showed lower dynamic range for Aβ and lower IT tau retention compared with women.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 10% sex difference in entorhinal cortex tau was hit within the Aβ cut-off in ADNI but far above the established cutoff in HABS.
“This is highlighted by the 10% sex difference in EC tau; although the ADNI clinically normal group hit this difference within the Aβ cut-off, the HABS clinically normal cohort exhibited this difference far above their established cutoff.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingnone givenThe ADNI clinically normal group were older, exhibited lower memory performance, and had greater dynamic range in tau SUVrs than the HABS clinically normal cohort.
“since the ADNI clinically normal group were older than the HABS clinically normal cohort, exhibited lower memory performance, and had greater dynamic range in tau SUVrs”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSeparate analyses including APOE were run because of missing APOE genotype data.
“There were some missing data for APOE genotype (n = 34 for HABS; n = 7 for ADNI), and as such, we ran separate analyses including main associations of APOE (model 2).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn a 2018 meta-analysis of multiple independent cohorts with CSF data, Hohman and colleagues found greater CSF total and phosphorylated tau in female APOE ε4 carriers than male carriers, with findings driven by abnormal levels of β-amyloid.
“Ina 2018 meta-analysis of multiple independent cohorts with CSF data, Hohman and colleagues10 found greater CSF total and phosphorylated tau in female APOE ε4 carriers than male carriers, with findings driven by abnormal levels of β-amyloid (Aβ).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hohman and colleagues10
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataSex × Aβ × APOE interactions were not included as a stand-alone analysis owing to low statistical power; they were included as an exploratory meta-analysis estimate.
“We did not include sex × Aβ × APOE interactions as a stand-alone analysis in the current study owing to low statistical power; however, we included it as an exploratory meta-analysis estimate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPost hoc analyses using robust linear regression examined the influence of outliers.
“We conducted post hoc analyses examining the influence of outliers using robust linear regression (using M estimation with Huber with the rlm package) on findings of interest.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study covaried for scan interval in analyses because some participants had a delay of longer than a year between tau and Aβ scans.
“Some participants had a duration delay of longer than a year between scans (HABS: n = 9; ADNI: n = 9 clinically normal individuals), and as such, we covaried for scan interval in our analyses.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataHierarchical linear regressions adjusted for age and delay between tau and Aβ scans.
“A series of hierarchical linear regressions were conducted to examine the influence of sex on the association between tau and Aβ, after adjusting for age and delay between tau and Aβ scans (model 1).”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe interaction was dependent on partial volume correction for the NCs from both cohorts, suggesting that partial volume adjustment facilitates detection of this association at lower levels of tau.
“However, this interaction was dependent on PVC for the NCs from both cohorts, suggesting that partial volume adjustment facilitates detection of this association at lower levels of tau.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWe did not have statistical power to robustly assess the issue of survival bias.
“We did not have statistical power to robustly assess this issue, and so the association of survival will need to be explored with larger cohorts.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataWe predominantly focused on temporal ROIs, although we did find some preliminary evidence of main effects of sex on an extratemporal region of the brain.
“Finally, we predominantly focused on temporal ROIs, although we did find some preliminary evidence of main effects of sex on an extratemporal region of the brain.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA strength of this study is the replication of our findings across 2 independent studies of aging with Aβ and tau PET.
“A strength of this study is the replication of our findings across 2 independent studies of aging with Aβ and tau PET.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataOwing to issues of power and limited follow-up neuropsychological observations post-tau scan in both cohorts, these preliminary null findings should be approached with caution.
“Owing to issues of power and limited follow-up neuropsychological observations post-tau scan in both cohorts, these preliminary null findings should be approached with caution.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationAnimal and cellular models of AD support a female-specific vulnerability to AD pathophysiology.
“Together, these animal and cellular models of AD support a female-specific vulnerability to AD pathophysiology.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThese cohorts are convenience samples and involve recruitment and sampling biases that may result in a lack of generalizability of findings.
“However, these cohorts are convenience samples and involve recruitment and sampling biases that may result in a lack of generalizability of findings.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisecitationAnimal models of AD have often reported sex differences in Aβ and tau deposition.
“Animal models of AD have often reported sex differences in Aβ and tau deposition.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The association of sex with regional tau deposition in clinically normal individuals remains unclear, and studies have yet to fully explore this notion.
“What remains unclear is the association of sex with regional tau deposition in clinically normal individuals.”
“To our knowledge, studies have yet to fully explore this notion,8 with little attention paid to elucidating sex differences in regional tau deposition in the context of Aβ burden and APOE ε4.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
ADNI percentage of women is incorrect in the abstract
MinorThe abstract reports 55 women among 103 ADNI participants as 51%; that fraction is 53.4%, consistent with the 53% reported in Methods.
Reported 51 · recomputed 53.398058
“103 clinically normal individuals from the Alzheimer’s Disease Neuroimaging Initiative (age range, 63–94 years; 55 women [51%])”
Overall mean age is below both cohort mean ages
MinorThe reported overall mean age of 74.2 years cannot be below both cohort means, 74.3 and 75.6 years, when those cohorts comprise the study population.
“The mean (SD) age of all individuals was 74.2 (7.6) years”
“mean [SD] age, 74.3 (8.0) years; 118 women [62%]). For ADNI, we included 103 individuals who were classified as clinically normal (global clinical dementia rating score, 0; mean [SD] age, 75.6 (6.3) years”
Stated PET acquisition duration conflicts with volume timings
MinorThe specified volumes total 12 × 15 + 57 × 60 = 3720 seconds, or 62 minutes, rather than four hours.
“4-hour dynamic acquisition of 69 volumes”
“(12 × 15 seconds, 57 × 60 seconds)”
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 2× · see citing works
“ForHABS, the timebetween the first tauPETscanand theclosestAβPETscanwasamedian (interquartile range)of54 (14-135) days (maximum,3.”
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works
Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer, R. A., Sidney, S., Selby, J., Johnston, S. C., & Yaffe, K. (2005) · Neurology · doi:10.1212/01.wnl.0000149519.47454.f2 · Cited by 1,238 · see citing works
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214 · see citing works
Clinical epidemiology of Alzheimer&rsquo;s disease: assessing sex and gender differences
Mielke, M., Vemuri, P., & Rocca, W. (2014) · Clinical Epidemiology · doi:10.2147/clep.s37929 · Cited by 1,021 · see citing works
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works
Self-citationTau positron emission tomographic imaging in aging and early <scp>A</scp> lzheimer disease
Johnson, K. A., Schultz, A., Betensky, R. A., Becker, J. A., Sepulcre, J., Rentz, D., Mormino, E., Chhatwal, J., Amariglio, R., Papp, K., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24546 · Cited by 986 · see citing works
Self-citationCorrection for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919 · see citing works
Sex modifies the <i>APOE</i> ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891 · see citing works
The Preclinical Alzheimer Cognitive Composite: Measuring Amyloid-Related Decline
Donohue, M. C., Sperling, R. A., Salmon, D. P., Rentz, D. M., Raman, R., Thomas, R. G., Weiner, M., & Aisen, P. S. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.803 · Cited by 860 · see citing works
Self-citationSex Differences in the Adult Human Brain: Evidence from 5216 UK Biobank Participants
Ritchie, S. J., Cox, S. R., Shen, X., Lombardo, M. V., Reus, L. M., Alloza, C., Harris, M. A., Alderson, H. L., Hunter, S., Neilson, E., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy109 · Cited by 855 · see citing works
<i>APOE</i> predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830 · see citing works
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734 · see citing works
Amyloid Deposition, Hypometabolism, and Longitudinal Cognitive Decline
Landau, S. M., Mintun, M., Joshi, A. D., Koeppe, R., Petersen, R. C., Aisen, P., Weiner, M., & Jagust, W. J. (2012) · Annals of Neurology · doi:10.1002/ana.23650 · Cited by 723 · see citing works
Self-citationApolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis
Neu, S. C., Pa, J., Kukull, W., Beekly, D., Kuzma, A., Gangadharan, P., Wang, L.-S., Romero, K., Arneric, S. P., Redolfi, A., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2188 · Cited by 674 · see citing works
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Baldereschi, M., Brayne, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1992 · Cited by 650 · see citing works
Perimenopause as a neurological transition state
Brinton, R. D., Yao, J., Yin, F., Mack, W. J., & Cadenas, E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.82 · Cited by 612 · see citing works
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
Jagust, W. J., Bandy, D., Chen, K., Foster, N. L., Landau, S. M., Mathis, C. A., Price, J. C., Reiman, E. M., Skovronsky, D., Koeppe, R. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.003 · Cited by 537 · see citing works
Self-citationProtective actions of sex steroid hormones in Alzheimer’s disease
Pike, C. J., Carroll, J. C., Rosario, E. R., & Barron, A. M. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.015 · Cited by 524 · see citing works
Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans
Aisen, P. S. S., Petersen, R. C., Donohue, M., Gamst, A. C., Raman, R., Thomas, R. G., Walter, S., Trojanowski, J. Q., Shaw, L. M. J., Beckett, L. A., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.006 · Cited by 516 · see citing works
Gender and incidence of dementia in the Framingham Heart Study from mid‐adult life
Chêne, G., Beiser, A., Au, R., Preis, S. R., Wolf, P. A., Dufouil, C., & Seshadri, S. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.10.005 · Cited by 499 · see citing works
In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
Cho, H., Choi, J. Y., Hwang, M. S., Kim, Y. J., Lee, H. M., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2016) · Annals of Neurology · doi:10.1002/ana.24711 · Cited by 499 · see citing works
(2020) · Clinical Epidemiology · doi:10.2147/clep · Cited by 468 · see citing works
Landau, S. M., Breault, C., Joshi, A. D., Pontecorvo, M. J., Mathis, C. A., Jagust, W. J., & Mintun, M. A. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109009 · Cited by 465 · see citing works
Self-citationComparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Maass, A., Landau, S., Baker, S. L., Horng, A., Lockhart, S. N., La Joie, R., Rabinovici, G. D., & Jagust, W. J. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.05.058 · Cited by 462 · see citing works
Self-citationAmyloid‐β associated cortical thinning in clinically normal elderly
Becker, J. A., Hedden, T., Carmasin, J., Maye, J., Rentz, D. M., Putcha, D., Fischl, B., Greve, D. N., Marshall, G. A., Salloway, S., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22333 · Cited by 342 · see citing works
Self-citationSex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau
Hohman, T. J., Dumitrescu, L., Barnes, L. L., Thambisetty, M., Beecham, G., Kunkle, B., Gifford, K. A., Bush, W. S., Chibnik, L. B., Mukherjee, S., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0821 · Cited by 340 · see citing works
Self-citationSex differences in Alzheimer’s disease and common neuropathologies of aging
Oveisgharan, S., Arvanitakis, Z., Yu, L., Farfel, J., Schneider, J. A., & Bennett, D. A. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1920-1 · Cited by 330 · see citing works
Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., Johnson, K. A., & Sperling, R. A. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2031 · Cited by 328 · see citing works
Self-citationSex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging
Mosconi, L., Berti, V., Quinn, C., McHugh, P., Petrongolo, G., Varsavsky, I., Osorio, R. S., Pupi, A., Vallabhajosula, S., Isaacson, R. S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004425 · Cited by 319 · see citing works
Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease
Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Ward, A. M., Huijbers, W., Rentz, D. M., Johnson, K. A., Sperling, R. A., & For the Alzheimer's Disease Neuroimaging Initiative, T. A. I. B. A. L. F. S. O. A. (2014) · Neurology · doi:10.1212/wnl.0000000000000431 · Cited by 290 · see citing works
Self-citationBuckley, R. F., Mormino, E. C., Amariglio, R. E., Properzi, M. J., Rabin, J. S., Lim, Y. Y., Papp, K. V., Jacobs, H. I. L., Burnham, S., Hanseeuw, B. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.04.010 · Cited by 276 · see citing works
Self-citationAugmented Senile Plaque Load in Aged Female β-Amyloid Precursor Protein-Transgenic Mice
Callahan, M. J., Lipinski, W. J., Bian, F., Durham, R. A., Pack, A., & Walker, L. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64064-3 · Cited by 274 · see citing works
Sexual dimorphism in predisposition to Alzheimer's disease
Fisher, D. W., Bennett, D. A., & Dong, H. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.04.004 · Cited by 270 · see citing works
Damoiseaux, J. S., Seeley, W. W., Zhou, J., Shirer, W. R., Coppola, G., Karydas, A., Rosen, H. J., Miller, B. L., Kramer, J. H., Greicius, M. D., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0305-12.2012 · Cited by 267 · see citing works
Gender, sex steroid hormones, and Alzheimer’s disease
Vest, R. S., & Pike, C. J. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.04.006 · Cited by 260 · see citing works
Harvard Aging Brain Study: Dataset and accessibility
Dagley, A. S., LaPoint, M. R., Huijbers, W., Hedden, T., McLaren, D. G., Chatwal, J. P., Papp, K. V., Amariglio, R. E., Blacker, D., Rentz, D. M., et al. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.03.069 · Cited by 231 · see citing works
Self-citationSex and Gender Differences in Alzheimer's Disease: Recommendations for Future Research
Carter, C. L., Resnick, E. M., Mallampalli, M., & Kalbarczyk, A. (2012) · Journal of Women's Health · doi:10.1089/jwh.2012.3789 · Cited by 231 · see citing works
Sex differences in Alzheimer's disease
Laws, K. R., Irvine, K., & Gale, T. M. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000401 · Cited by 216 · see citing works
Howlett, D. R., Richardson, J. C., Austin, A., Parsons, A. A., Bate, S. T., Davies, D. C., & Gonzalez, M. I. (2004) · Brain Research · doi:10.1016/j.brainres.2004.05.029 · Cited by 212 · see citing works
Dementia and Alzheimer Disease Incidence Rates Do Not Vary by Sex in Rochester, Minn
Edland, S. D., Rocca, W. A., Petersen, R. C., Cha, R. H., & Kokmen, E. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1589 · Cited by 184 · see citing works
Indicators of amyloid burden in a population-based study of cognitively normal elderly
Mielke, M. M., Wiste, H. J., Weigand, S. D., Knopman, D. S., Lowe, V. J., Roberts, R. O., Geda, Y. E., Swenson-Dravis, D. M., Boeve, B. F., Senjem, M. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e2696 · Cited by 163 · see citing works
Beydoun, M. A., Boueiz, A., Abougergi, M. S., Kitner-Triolo, M. H., Beydoun, H. A., Resnick, S. M., O'Brien, R., & Zonderman, A. B. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.017 · Cited by 139 · see citing works
Tau imaging in neurodegenerative diseases
Dani, M., Brooks, D. J., & Edison, P. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3231-2 · Cited by 125 · see citing works
<i>APOE</i> genotype and early β-amyloid accumulation in older adults without dementia
Lim, Y. Y., Mormino, E. C., Initiative, F. T. A. D. N., Initiative, A. D. N., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004336 · Cited by 125 · see citing works
Self-citationFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · see citing works
Grimm, A., Biliouris, E. E., Lang, U. E., Götz, J., Mensah‐Nyagan, A. G., & Eckert, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1988-x · Cited by 104 · see citing works
Lindahl‐Jacobsen, R., Martinussen, T., Christiansen, L., Jeune, B., Andersen‐Ranberg, K., Vaupel, J. W., & Christensen, K. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00626.x · Cited by 66 · see citing works
Proximity to Parental Symptom Onset and Amyloid-β Burden in Sporadic Alzheimer Disease
Villeneuve, S., Vogel, J. W., Gonneaud, J., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.5135 · Cited by 25 · see citing works
Flagged first, then by citations
4 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465 · see citing works
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001 · see citing works
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425 · see citing works
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
Vogel, J. W., Iturria‐Medina, Y., Strandberg, O. T., Smith, R. A., Levitis, E., Evans, A. C., Hansson, O., Initiative, A. D. N., Weiner, M. W., Aisen, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15701-2 · Cited by 521 · see citing works
Self-citationSuárez‐Calvet, M., Karikari, T. K., Ashton, N. J., Lantero Rodríguez, J., Milà‐Alomà, M., Gispert, J. D., Salvadó, G., Minguillon, C., Fauria, K., Shekari, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012921 · Cited by 401 · see citing works
Mechanisms of sex differences in Alzheimer’s disease
Lopez-Lee, C., Torres, E. R. S., Carling, G., & Gan, L. (2024) · Neuron · doi:10.1016/j.neuron.2024.01.024 · Cited by 376 · see citing works
Bellaver, B., Povala, G., Ferreira, P. C. L., Ferrari-Souza, J. P., Leffa, D. T., Lussier, F. Z., Benedet, A. L., Ashton, N. J., Triana-Baltzer, G., Kolb, H. C., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02380-x · Cited by 319 · see citing works
Self-citationAPOE2: protective mechanism and therapeutic implications for Alzheimer’s disease
Li, Z., Shue, F., Zhao, N., Shinohara, M., & Bu, G. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00413-4 · Cited by 306 · see citing works
Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
Therriault, J., Benedet, A. L., Pascoal, T. A., Mathotaarachchi, S., Chamoun, M., Savard, M., Thomas, E., Kang, M. S., Lussier, F., Tissot, C., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4421 · Cited by 256 · see citing works
Sex and gender differences in cognitive resilience to aging and Alzheimer's disease
Arenaza‐Urquijo, E. M., Boyle, R., Casaletto, K., Anstey, K. J., Vila‐Castelar, C., Colverson, A., Palpatzis, E., Eissman, J. M., Kheng Siang Ng, T., Raghavan, S., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13844 · Cited by 223 · see citing works
Self-citationMielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12662 · Cited by 198 · see citing works
Veitch, D. P., Weiner, M. W., Aisen, P. S., Beckett, L. A., DeCarli, C., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., Landau, S. M., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12422 · Cited by 184 · see citing works
Self-citationA second X chromosome contributes to resilience in a mouse model of Alzheimer’s disease
Davis, E. J., Broestl, L., Abdulai-Saiku, S., Worden, K., Bonham, L. W., Miñones-Moyano, E., Moreno, A. J., Wang, D., Chang, K., Williams, G., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5677 · Cited by 176 · see citing works
Sex-driven modifiers of Alzheimer risk
Rahman, A., Schelbaum, E., Hoffman, K., Diaz, I., Hristov, H., Andrews, R. D., Jett, S., Jackson, H. C., Lee, A., Sarva, H., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009781 · Cited by 165 · see citing works
Ossenkoppele, R., Lyoo, C. H., Jester-Broms, J., Sudre, C. H., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R., Strandberg, O., Palmqvist, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.5154 · Cited by 161 · see citing works
Ferretti, M. T., Martínková, J., Biskup, E. M., Benke, T., Gialdini, G., Nedelská, Z., Rauen, K., Mantua, V., Religa, D., Hort, J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14174 · Cited by 150 · see citing works
Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
Eikelboom, W., Pan, M., Ossenkoppele, R., Coesmans, M., Gatchel, J., Ismail, Z., Lanctôt, K., Fischer, C. E., Mortby, M., van den Berg, E., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00991-z · Cited by 126 · see citing works
X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women
Yan, Y., Wang, X., Chaput, D., Shin, M.-K., Koh, Y., Gan, L., Pieper, A. A., Woo, J.-A. A., & Kang, D. E. (2022) · Cell · doi:10.1016/j.cell.2022.09.002 · Cited by 144 · see citing works
Coughlan, G., Betthauser, T. J., Boyle, R. T., Koscik, R. L., Klinger, H. M., Chibnik, L. B., Jonaitis, E. M., Yau, W. W., Wenzel, A., Christian, B. T., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.0455 · Cited by 136 · see citing works
Self-citationThe accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
Smith, R. A., Strandberg, O. T., Mattsson, N., Leuzy, A., Palmqvist, S., Pontecorvo, M. J., Devous, M. D., Ossenkoppele, R., & Hansson, O. (2020) · Brain · doi:10.1093/brain/awaa327 · Cited by 132 · see citing works
Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline
Buckley, R. F., Scott, M. R., Jacobs, H. I. L., Schultz, A. P., Properzi, M. J., Amariglio, R. E., Hohman, T. J., Mayblyum, D. V., Rubinstein, Z. B., Manning, L. K., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25878 · Cited by 132 · see citing works
Self-citationProtective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Seto, M., Weiner, R. L., Dumitrescu, L., & Hohman, T. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00452-5 · Cited by 135 · see citing works
Self-citationSex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone
Sundermann, E. E., Panizzon, M. S., Chen, X., Andrews, M., Galasko, D. R., Banks, S. J., & Initiative, A. D. N. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00310-x · Cited by 102 · see citing works
Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
Dennison, J. L., Ricciardi, N. R., Lohse, I., Volmar, C., & Wahlestedt, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201014 · Cited by 100 · see citing works
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
Buckley, R. F., O’Donnell, A., McGrath, E. R., Jacobs, H. I. L., Lois, C., Satizábal, C. L., Ghosh, S., Rubinstein, Z. B., Murabito, J. M., Sperling, R. A., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26382 · Cited by 101 · see citing works
Self-citationLocal Sleep and Alzheimer’s Disease Pathophysiology
Mander, B. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.525970 · Cited by 97 · see citing works
Dubal, D. B. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00018-7 · Cited by 88 · see citing works
Sex and Gender Differences in Neurodegenerative Diseases: Challenges for Therapeutic Opportunities
Bianco, A., Antonacci, Y., & Liguori, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076354 · Cited by 88 · see citing works
Sex-specific effects of microglial activation on Alzheimer’s disease proteinopathy in older adults
Casaletto, K. B., Nichols, E. L., Aslanyan, V., Simone, S. M., Rabin, J. S., Joie, R. L., Brickman, A. M., Dams-O’Connor, K., Palta, P., Kumar, R. G., et al. (2022) · Brain · doi:10.1093/brain/awac257 · Cited by 87 · see citing works
Self-citationSex Differences in the Gut-Brain Axis: Implications for Mental Health
Holingue, C., Budavari, A. C., Rodriguez, K. M., Zisman, C. R., Windheim, G., & Fallin, M. D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01202-y · Cited by 85 · see citing works
Gamache, J., Yun, Y., & Chiba-Falek, O. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045211 · Cited by 84 · see citing works
Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy
Lesman‐Segev, O. H., Joie, R. L., Stephens, M. L., Sonni, I., Tsai, R. M., Bourakova, V., Visani, A. V., Edwards, L., O’Neil, J. P., Baker, S. L., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102025 · Cited by 81 · see citing works
Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau
Digma, L. A., Madsen, J. R., Rissman, R. A., Jacobs, D. M., Brewer, J. B., Banks, S. J., Initiative, A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa025 · Cited by 80 · see citing works
Self-citationLatest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
Milà‐Alomà, M., Suárez‐Calvet, M., & Molinuevo, J. L. (2019) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286419888819 · Cited by 78 · see citing works
APOE effects on regional tau in preclinical Alzheimer’s disease
Young, C. B., Johns, E., Kennedy, G., Belloy, M. E., Insel, P. S., Greicius, M. D., Sperling, R. A., Johnson, K. A., Poston, K. L., Mormino, E. C., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00590-4 · Cited by 80 · see citing works
Self-citationNicoletti, A. S. Q., Baschi, R., Cicero, C. E., Iacono, S., Re, V. L., Luca, A., Schirò, G., & Monastero, R. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111821 · Cited by 76 · see citing works
Ramanan, V. K., Castillo, A. M., Knopman, D. S., Graff‐Radford, J., Lowe, V. J., Petersen, R. C., Jack, C. R., Mielke, M. M., & Vemuri, P. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.13909 · Cited by 71 · see citing works
Demarest, T. G., Varma, V. R., Estrada, D. J., Babbar, M., Basu, S., Mahajan, U. V., Moaddel, R., Croteau, D. L., Thambisetty, M., Mattson, M. P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02152-8 · Cited by 70 · see citing works
Udeh-Momoh, C., & Watermeyer, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101459 · Cited by 67 · see citing works
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels
Steward, A., Biel, D., Dewenter, A., Roemer, S., Wagner, F., Dehsarvi, A., Rathore, S., Otero Svaldi, D., Higgins, I., Brendel, M., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.4038 · Cited by 67 · see citing works
Farrell, M. E., Papp, K. V., Buckley, R. F., Jacobs, H. I. L., Schultz, A. P., Properzi, M. J., Vannini, P., Hanseeuw, B. J., Rentz, D. M., Johnson, K. A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200137 · Cited by 63 · see citing works
Self-citationIulita, M. F., Bejanin, A., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernández, S., Altuna, M., Pegueroles, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad074 · Cited by 68 · see citing works
Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: a meta-analysis
Coughlan, G. T., Klinger, H. M., Boyle, R., Betthauser, T. J., Binette, A. P., Christenson, L., Chadwick, T., Hansson, O., Harrison, T. M., Healy, B., et al. (2025) · JAMA Neurology · doi:10.1001/jamaneurol.2025.0013 · Cited by 69 · see citing works
Self-citationFrequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
Moscoso, A., Heeman, F., Raghavan, S., Costoya‐Sánchez, A., van Essen, M., Mainta, I., Camacho, V., Fonseca, O. D. R., Silva‐Rodríguez, J., Perissinotti, A., et al. (2025) · JAMA · doi:10.1001/jama.2025.7817 · Cited by 70 · see citing works
Self-citationLiu, M., Paranjpe, M. D., Zhou, X., Duy, P. Q., Goyal, M. S., Benzinger, T. L. S., Lu, J., Wang, R., & Zhou, Y. (2019) · Theranostics · doi:10.7150/thno.35366 · Cited by 65 · see citing works
Tau pathology in cognitively normal older adults
Ziontz, J., Bilgel, M., Shafer, A. T., Moghekar, A., Elkins, W., Helphrey, J. H., Gómez, G., June, D., McDonald, M. A., Dannals, R. F., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.007 · Cited by 65 · see citing works
Tissot, C., Therriault, J., Pascoal, T. A., Chamoun, M., Lussier, F. Z., Savard, M., Mathotaarachchi, S. S., Benedet, A. L., Thomas, E. M., Parsons, M., et al. (2021) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12154 · Cited by 63 · see citing works
Cumplido‐Mayoral, I., García-Prat, M., Operto, G., Falcón, C., Shekari, M., Cacciaglia, R., Milà‐Alomà, M., Lorenzini, L., Ingala, S., Wink, A. M., et al. (2023) · eLife · doi:10.7554/elife.81067 · Cited by 68 · see citing works
The complex pathway between amyloid β and cognition: implications for therapy
Jagust, W. J., Teunissen, C. E., & DeCarli, C. S. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00128-x · Cited by 63 · see citing works
Challenges and Advancements in the Health-Related Quality of Life of Older People
Rony, M. K. K., Parvin, M. R., Wahiduzzaman, M., Akter, K., & Ullah, M. (2024) · Advances in Public Health · doi:10.1155/2024/8839631 · Cited by 63 · see citing works
Edwards, L., Joie, R. L., Iaccarino, L., Strom, A., Baker, S. L., Casaletto, K. B., Cobigo, Y., Grant, H. E., Kim, M., Kramer, J. H., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.003 · Cited by 61 · see citing works
Shaw, C., Hayes-Larson, E., Glymour, M. M., Dufouil, C., Hohman, T. J., Whitmer, R. A., Kobayashi, L. C., Brookmeyer, R., & Mayeda, E. R. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1001 · Cited by 60 · see citing works
Self-citationSex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals
Yan, S., Zheng, C., Paranjpe, M. D., Li, Y., Li, W., Wang, X., Benzinger, T. L. S., Lu, J., & Zhou, Y. (2021) · Brain · doi:10.1093/brain/awab160 · Cited by 61 · see citing works
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Huang, S., Wang, Y.-J., & Guo, J.-H. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00836-7 · Cited by 52 · see citing works
Mander, B. A., Dave, A., Lui, K. K., Sprecher, K. E., Berisha, D. E., Chappel-Farley, M. G., Chen, I. Y., Riedner, B. A., Heston, M. B., Suridjan, I., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac135 · Cited by 60 · see citing works
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Bocancea, D. I., Svenningsson, A. L., van Loenhoud, A. C., Groot, C., Barkhof, F., Strandberg, O. T., Smith, R. A., Initiative, A. D. N., Weiner, M. W., Aisen, P., et al. (2023) · Brain · doi:10.1093/brain/awad100 · Cited by 57 · see citing works
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease
Martínková, J., Quevenco, F., Karcher, H., Ferrari, A., Sandset, E. C., Szoeke, C. E. I., Hort, J., Schmidt, R., Chadha, A. S., & Ferretti, M. T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.24124 · Cited by 60 · see citing works
Belonwu, S., Li, Y., Bunis, D. G., Rao, A. A., Solsberg, C. W., Tang, A., Fragiadakis, G. K., Dubal, D. B., Oskotsky, T., & Sirota, M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02591-8 · Cited by 54 · see citing works
Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease
Depypere, H. T., Vergallo, A., Lemercier, P., Lista, S., Benedet, A. L., Ashton, N. J., Cavedo, E., Zetterberg, H., Blennow, K., Vanmechelen, E., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12759 · Cited by 60 · see citing works
Ossenkoppele, R., Coomans, E. M., Apostolova, L. G., Baker, S. L., Barthel, H., Beach, T. G., Benzinger, T. L. S., Betthauser, T. J., Bischof, G. N., Bottlaender, M., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02000-6 · Cited by 56 · see citing works
Self-citationWisch, J. K., Meeker, K. L., Gordon, B. A., Flores, S. E., Dincer, A., Grant, E., Benzinger, T. L. S., Morris, J. C., & Ances, B. M. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000393 · Cited by 56 · see citing works
Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00408-2 · Cited by 55 · see citing works
Self-citationBiechele, G., Franzmeier, N., Blume, T., Ewers, M., Medina-Luque, J., Eckenweber, F., Sacher, C., Beyer, L., Ruch, F., Lindner, S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02046-2 · Cited by 53 · see citing works
White matter hyperintensities are associated with subthreshold amyloid accumulation
Moscoso, A., Rey-Bretal, D., Silva-Rodríguez, J., Aldrey, J. M., Cortés, J., Pías-Peleteiro, J., Ruibal, Á., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116944 · Cited by 49 · see citing works
“Amyloid-related tau pathology has been found to be higher in females (Buckley et al., 2019); however, to the best of our knowledge, neither differences in amyloid burden, particularly in the subthreshold regime, nor potential biological mechanisms have been reported before.”
Boccalini, C., Peretti, D. E., Scheffler, M., Mu, L., Griffa, A., Dardel, N. T., Allali, G., Prior, J. O., Ashton, N. J., Zetterberg, H., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01684-z · Cited by 51 · see citing works
Sex differences in Alzheimer’s disease: metabolic reprogramming and therapeutic intervention
Demetrius, L., Eckert, A., & Grimm, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.09.004 · Cited by 50 · see citing works
Wang, Y., Therriault, J., Servaes, S., Tissot, C., Rahmouni, N., Macedo, A. C., Arias, J. F., Mathotaarachchi, S. S., Benedet, A. L., Stevenson, J., et al. (2023) · Brain · doi:10.1093/brain/awad397 · Cited by 51 · see citing works
Therriault, J., Pascoal, T. A., Savard, M., Benedet, A. L., Chamoun, M., Tissot, C., Lussier, F. Z., Kang, M. S., Thomas, E. M., Terada, T., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000011081 · Cited by 51 · see citing works
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
Ossenkoppele, R., Leuzy, A., Cho, H., Sudre, C. H., Strandberg, O. T., Smith, R. A., Palmqvist, S., Mattsson, N., Olsson, T., Jögi, J., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05099-w · Cited by 53 · see citing works
Bollack, A., Pemberton, H., Collij, L. E., Markiewicz, P. J., Cash, D. M., Farrar, G., & Barkhof, F. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13158 · Cited by 49 · see citing works
Mishra, A., Wang, Y., Yin, F., Vitali, F., Rodgers, K. E., Soto, M., Mosconi, L., Wang, T., & Brinton, R. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101542 · Cited by 44 · see citing works
Sex influences the effects of APOE genotype and Alzheimer’s diagnosis on neuropathology and memory
Duarte‐Guterman, P., Albert, A., Barha, C. K., Galea, L. A. M., & Initiative, O. B. O. T. A. D. N. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105248 · Cited by 45 · see citing works
Sex differences in off-target binding using tau positron emission tomography
Smith, R. A., Strandberg, O. T., Leuzy, A., Betthauser, T. J., Johnson, S. C., Pereira, J. B., & Hansson, O. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102708 · Cited by 46 · see citing works
Egroo, M. V., van Hooren, R. W. E., & Jacobs, H. I. L. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00902-8 · Cited by 44 · see citing works
Self-citationWolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A. E., Hansson, O., Nordberg, A. K., Frisoni, G. B., Garibotto, V., & Ossenkoppele, R. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05118-w · Cited by 47 · see citing works
Saloner, R., VandeVrede, L. A., Asken, B. M., Paolillo, E. W., Gontrum, E. Q., Wolf, A. A., Lario‐Lago, A., Milà‐Alomà, M., Triana‐Baltzer, G., Kolb, H. C., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13454 · Cited by 46 · see citing works
Parkinson disease clinical subtypes: key features & clinical milestones
Campbell, M. C., Myers, P. S., Weigand, A. J., Foster, E. R., Cairns, N. J., Jackson, J. J., Lessov‐Schlaggar, C. N., & Perlmutter, J. S. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51102 · Cited by 44 · see citing works
Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
Coomans, E. M., van Westen, D., Binette, A. P., Strandberg, O. T., Spotorno, N., Serrano, G. E., Beach, T. G., Palmqvist, S., Stomrud, E., Ossenkoppele, R., et al. (2023) · Brain · doi:10.1093/brain/awad317 · Cited by 43 · see citing works
The sex-specific interaction of the microbiome in neurodegenerative diseases
Cox, L. M., Abou‐El‐Hassan, H., Maghzi, A. H., Vincentini, J., & Weiner, H. L. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146385 · Cited by 42 · see citing works
Marongiu, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00242 · Cited by 44 · see citing works
Disappearing metabolic youthfulness in the cognitively impaired female brain
Beheshti, I., Nugent, S., Potvin, O., & Duchesne, S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.026 · Cited by 42 · see citing works
Sex differences in default mode network connectivity in healthy aging adults
Ficek, B., Horien, C. L., Ju, S., Xu, W., Li, N., Lacadie, C., Shen, X., Scheinost, D., Constable, R. T., & Fredericks, C. A. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac491 · Cited by 42 · see citing works
Cai, Y. Q., Du, J., Li, A., Zhu, Y., Xu, L., Sun, K., Ma, S., Guo, T., & Initiative, A. D. N. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01178-w · Cited by 41 · see citing works
Sass, D., Guedes, V. A., Smith, E. G., Vorn, R., Devoto, C., Edwards, K. A., Mithani, S., Hentig, J., Lai, C., Wagner, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.746491 · Cited by 40 · see citing works
Association of CD14 with incident dementia and markers of brain aging and injury
Pase, M. P., Himali, J. J., Beiser, A., DeCarli, C. S., McGrath, E. R., Satizábal, C. L., Aparicio, H. J., Adams, H. H. H., Reiner, A. P., Longstreth, W. T., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000008682 · Cited by 38 · see citing works
Pereira, J. B., Harrison, T. M., Joie, R. L., Baker, S. L., & Jagust, W. J. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04669-x · Cited by 39 · see citing works
Subramaniapillai, S., Rajagopal, S., Snytte, J., Otto, A. R., Einstein, G., & Rajah, M. N. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102620 · Cited by 39 · see citing works
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials
Buckley, R. F., Gong, J., & Woodward, M. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1059 · Cited by 38 · see citing works
Self-citationCieri, F., Zhuang, X., Cordes, D., Kaplan, N., Cummings, J. L., Caldwell, J., & Initiative, A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00973-1 · Cited by 37 · see citing works
Emrani, S., & Sundermann, E. E. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101184 · Cited by 45 · see citing works
Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M. S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab126 · Cited by 36 · see citing works
Alzheimer disease seen through the lens of sex and gender
Castro‐Aldrete, L., Einsiedler, M., Martínková, J., Depypere, H. T., Ang, T. F. A., Mielke, M. M., Sindi, S., Eyre, H. A., Au, R., Dimech, A. S., et al. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01071-0 · Cited by 39 · see citing works
Lim, Y. Y., Maruff, P. T., Barthélemy, N. R., Goate, A., Hassenstab, J. J., Sato, C., Fagan, A. M., Benzinger, T. L. S., Xiong, C., Cruchaga, C., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2021.5181 · Cited by 36 · see citing works
Self-citationSex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity
Tsiknia, A., Sundermann, E., Reas, E. T., Edland, S., Brewer, J., Galasko, D., & Banks, S. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-01106-4 · Cited by 28 · see citing works
In vivo network models identify sex differences in the spread of tau pathology across the brain
Shokouhi, S., Taylor, W. D., Albert, K., Kang, H., Newhouse, P. A., & Initiative, T. A. D. N. (2020) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1002/dad2.12016 · Cited by 35 · see citing works
Microglial heterogeneity in aging and Alzheimer's disease: Is sex relevant?
Delage, C. I., Šimončičová, E., & Tremblay, M. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.03.006 · Cited by 35 · see citing works
Vila‐Castelar, C., Chen, Y., Langella, S., Lopera, F. J., Zetterberg, H., Hansson, O., Dage, J. L., Janelidzde, S., Su, Y., Chen, K., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13314 · Cited by 35 · see citing works
Sex differences in in vivo tau neuropathology in a multiethnic sample of late middle-aged adults
Palta, P., Rippon, B., Tahmi, M., Pardo, M., Johnson, A. S., Tomljanovic, Z., He, H., Laing, K. K., Razlighi, Q. R., Teresi, J. A., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.007 · Cited by 32 · see citing works
Scene memory and hippocampal volume in middle-aged women with early hormone loss
Gervais, N. J., Gravelsins, L. L., Brown, A., Reuben, R. B., Karkaby, L., Baker‐Sullivan, E., Mendoza, L., Lauzon, C., Almey, A., Foulkes, W. D., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.05.003 · Cited by 32 · see citing works
Misiura, M. B., Butts, B., Hammerschlag, B., Munkombwe, C., Bird, A., Fyffe, M., Hemphill, A., Dotson, V. M., & Wharton, W. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01408-x · Cited by 29 · see citing works
- Authors
- Buckley, R. F., Mormino, E. C., Rabin, J. S., Hohman, T. J., Landau, S., Hanseeuw, B. J., Jacobs, H. I. L., Papp, K. V., Amariglio, R. E., Properzi, M. J., Schultz, A. P., Kirn, D., Scott, M. R., Hedden, T., Farrell, M., Price, J., Chhatwal, J., Rentz, D. M., Villemagne, V. L., Johnson, K. A., & Sperling, R. A.
- Affiliations
- Brigham and Women's Hospital (US)
- Stanford University (US)
- Harvard University (US)
- Vanderbilt University (US)
- University of California, Berkeley (US)
- Cliniques Universitaires Saint-Luc (BE)
- Austin Hospital (AU)
- Corresponding author
- Sperling, Reisa A.
- ORCID
- Buckley, Rachel F.
- Mormino, Elizabeth C.
- Rabin, Jennifer S.
- Hohman, Timothy J.
- Hanseeuw, Bernard J.
- Jacobs, Heidi I. L.
- Papp, Kathryn V.
- Amariglio, Rebecca E.
- Properzi, Michael J.
- Schultz, Aaron P.
- Scott, Matthew R.
- Hedden, Trey
- Farrell, Michelle
- Price, Julie
- Chhatwal, Jasmeer
- Rentz, Dorene M.
- Villemagne, Victor L.
- Johnson, Keith A.
- Sperling, Reisa A.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-05-01
- Volume
- 76
- Issue
- 5
- Pages
- 542
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC6515599
- OpenAlex
- W2913192031
- Semantic Scholar
- 7b6811fdb97945fde9c6476aca67038bda3fbac8
- Cited by
- 373
- References
- 54
- Citations by year
- 2026: 58 · 2025: 71 · 2024: 37 · 2023: 61 · 2022: 44 · 2021: 47 · 2020: 42 · 2019: 13
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (submittedVersion)
- PubMed Central (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Massachusetts General Hospital
- Vanderbilt University
- Vanderbilt University Medical Center
- Universiteit Maastricht
- Centre d'Imagerie BioMédicale
- National Institutes of Health (5k01ag049164-06, 5r21ag059941-02, 5k01ag051718-05, 5p30ag062421-07)
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
- National Institute on Aging (P30-AG062421, R21-AG059941, R01AG059716, K24 AG035007, R01 AG046396, K01-AG049164), K99AG061238, K01‐AG051718, P01AG036694, R00AG061238)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- sex differences, Alzheimer's disease, amyloid-beta, APOE ε4, entorhinal cortex, Pittsburgh compound B, flortaucipir, florbetapir, amyloid PET, tau PET, neurodegeneration biomarkers, temporal lobe, brain aging
- MeSH terms
- Aged, Aged, 80 and over, Aniline Compounds, Brain, Carbolines, Contrast Media, Cross-Sectional Studies, Ethylene Glycols, Female, Humans, Male, Middle Aged, Sex Factors, Temporal Lobe, Thiazoles, Amyloid beta-Peptides, tau Proteins, Entorhinal Cortex, Positron-Emission Tomography, Apolipoprotein E4, Healthy Volunteers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-18.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-18.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review